NORCROSS, Ga., Sept. 21, 2026 /PRNewswire/ -- Hi-Tech Pharmaceuticals, Inc., today announced an additional capacity to produce Phosphagen™, the world's most trusted creatine brand Creatine Monohydrate. Phosphagen™ was released in 1993 by Experimental and Applied Sciences (EAS), a...
Hence then, the article about hi tech pharmaceuticals invests into expanding and automating production of phosphagen brand creatine to keep pace with the growing demand for high quality creatine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hi-Tech Pharmaceuticals Invests Into Expanding and Automating Production of Phosphagen™ Brand Creatine to Keep Pace with the Growing Demand for High Quality Creatine )
Also on site :
- William Shatner, 95, Walked Onstage With a Band Nobody Expected Him to Front; the ‘Star Trek’ Legend Covered Ozzy Osbourne and Metallica in Chicago
- Sean Hogan’s ‘The Dark Gets In’ Boarded for Worldwide Sales by Blue Finch Films Ahead of Beyond Fest Bow (EXCLUSIVE)
- Envision Energy Powers Morocco's First Large-Scale Battery Storage System at OCP's Benguerir Mining Site